FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
07/05/2025
Back to search
Official data from USPTO
HISUN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/06/2025
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
07/27/2022
Registration date
12/31/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
07/06/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CN
Examiner
EULIN, INGRID
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
the stylized square figure with the stylized wording HISUN below. The lower left part of the aforesaid square figure is a stylized right-angled triangle whose right angle points to the center of the square.
Holders and representatives
Holders
Zhejiang Hisun Pharmaceutical Co., Ltd
Representatives
Paulo A. de Almeida Patel & Almeida PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposespharmaceutical preparations for suppressing tumorsmedicines for the treatment of hematopathycardiovascular pharmaceuticalsanti-infectivesstimulatory medications for use in weight reduction programsanalgesics; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; chemical preparations for pharmaceutical or medical purposesfor the treatment of cancer; medicines made of chinese traditional medicinal herbs; camphor for medical purposes; vermin destroying preparations; diagnostic radiopharmaceutical preparations; dietetic foods adapted for medical purposes; medicines for veterinary purposesanti-infective products for veterinary useanthelmintics; bacteriological culture mediums
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/18/2025
FIMP
FINAL DISPOSITION PROCESSED
06/18/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/31/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/17/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/31/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/31/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/10/2024
GNSL
LETTER OF SUSPENSION E-MAILED
01/10/2024
CNSL
SUSPENSION LETTER WRITTEN
01/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2023
RFNT
REFUSAL PROCESSED BY IB
07/22/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/25/2023
RFRR
REFUSAL PROCESSED BY MPU
06/25/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/19/2023
CNRT
NON-FINAL ACTION WRITTEN
05/18/2023
DOCK
ASSIGNED TO EXAMINER
05/15/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/16/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/08/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/02/2023
Continuous trademark protection
Get notified about every new filing that threatens HISUN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.